Overview

This trial is active, not recruiting.

Condition multiple sclerosis
Sponsor Mount Sinai Rehabilitation Hospital
Collaborator National Multiple Sclerosis Society
Start date October 2013
End date October 2016
Trial size 267 participants
Trial identifier NCT02398149, 13-12-002-E, RG 4815A2/2

Summary

Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of community-based persons with MS across the International Classification of Functioning, Disability & Health (ICF) domains and constructs.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective cross-sectional
Arm

Primary Outcomes

Measure
Prevalance of Impairment in the Upper Extremity
time frame: 3hours

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Confirmed clinical Clinical diagnosis of MS - Receive MS care at the Mandell MS Center - Cognitively able to understand directions and complete protocol - Signed consent form approved by the Saint Francis Institutional Review Board - 18 years of age or older Exclusion Criteria: - Unwilling or unable to complete assessments

Additional Information

Official title Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis
Trial information was received from ClinicalTrials.gov and was last updated in March 2016.
Information provided to ClinicalTrials.gov by Mount Sinai Rehabilitation Hospital.